| Authors: |
Vandemaele M; Radiation Oncology Department, Ghent University Hospital and Ghent University, Ghent, Belgium. Electronic address: miet.vandemaele@ugent.be., Lewison G; Institute of Cancer Policy, King's College London, London, United Kingdom; Evalumetrics Ltd, London, United Kingdom., Martinussen H; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands., Borràs JM; Department of Clinical Sciences, University of Barcelona and Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Leech M; Applied Radiation Therapy Trinity, Discipline of Radiation Therapy, School of Medicine, Trinity College Dublin, Ireland; Trinity St. James's Cancer Institute, Trinity College Dublin, Ireland., Aznar M; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom., Blanchard P; Department of Radiation Oncology, Gustave Roussy Cancer Campus, Oncostat U1018 INSERM, Université Paris-Saclay, Gustave-Roussy, Villejuif, France., Lievens Y; Radiation Oncology Department, Ghent University Hospital and Ghent University, Ghent, Belgium., Aggarwal A; Institute of Cancer Policy, King's College London, London, United Kingdom; Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom. |